Ica Group Wealth Management, LLC Ocuphire Pharma, Inc. Transaction History

Ica Group Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$1.89 - $3.27 $37 - $65	-20 Reduced 66.67%	10 $0
Q4 2023 Mar 07, 2024	BUY	$2.59 - $3.64 $77 - $109	30 New	30 $0
Q2 2023 Aug 11, 2023	SELL	$3.63 - $6.38 $7 - $12	-2 Reduced 6.25%	30 $0
Q4 2022 Feb 14, 2023	BUY	$2.04 - $3.53 $65 - $112	32 New	32 $0

2.58M

14.1K

800

Ticker OCUP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,579,800
Market Cap $20.2M
Description
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...

Get notified when there are updates to the investment portfolio of Ica Group Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Ica Group Wealth Management, LLC with notifications on news.